Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether free asymptomatic covid-19 testing will be available to people who are immunocompromised.
Answered by Maggie Throup
From 1 April 2022, free universal access to lateral flow device tests for the public in England will end. We will continue to make testing available for a small number of at risk groups. Further details on eligible groups will be made available in due course.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans to implement the recommendations on sickle cell disease care made by the sickle cell all-party Parliamentary group in its report, No One’s Listening, published 15 November 2021.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department will work with relevant organisations to consider the recommendations and develop an action plan.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what programme of training is being implemented to ensure that the NHS workforce has adequate training on sickle cell disease.
Answered by Edward Argar - Minister of State (Ministry of Justice)
The haematology medical curriculum includes understanding sickle cell and thalassemia as core competencies. Health Education England (HEE) has held discussions with the Royal Colleges of Pathology and Physicians to ensure this curriculum is deliverable to all four nations, in line with General Medical Council standards.
HEE additionally provides two ‘eLearning for healthcare’ programmes with sickle cell content: NHS Screening Programmes and the Maternity Support Worker Programme. Wider eLearning programmes with sessions on sickle cell disease include anaesthesia, radiology, and pain.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NHS trusts meet the clinical guidelines on treatment for sickle cell disease.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
NHS England and NHS Improvement have service specifications for Haemoglobinopathy Co-ordinating Centres and Specialist Haemoglobinopathy Teams describing the standards and clinical guidelines to be met. The delivery of these services is reviewed by regional teams, with providers required to ensure they meet National Institute for Health and Care Excellence (NICE) guidelines. Compliance with NICE guidelines on managing acute sickle cell episodes is monitored through NHS England and NHS Improvement’s quality metrics. NHS England and NHS Improvement are developing an action plan for further quality improvement in the care of patients with sickle cell disease.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure (a) all people with sickle cell disease receive equal access to red cell exchange therapy and other treatments and (b) the organisation of sickle cell care across the NHS is efficient in patients receiving treatment in a sufficient timeframe.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To coordinate equitable, efficient and timely access to red cell exchange therapy and other treatments for sickle cell disease, there are 10 Haemoglobinopathy Co-ordinating Centres (HCCs), each overseeing Specialist Haemoglobinopathy Teams (SHTs) and local haemoglobinopathy teams. NHS England and NHS Improvement have service specifications for HCCs and SHTs which support providers and clinical teams, describing the standards and clinical guidelines to be met. The service specifications ensure standardised care and equitable delivery across England.